Hipocondría en la infancia y adolescencia. Revisión bibliográfica
PDF

Palabras clave

hipocondría
psiquiatría infanto-juvenil
trastorno somatomorfo
síntomas somáticos
trastorno de ansiedad por enfermedad

Cómo citar

Gómez Vallejo, S., Alonso González, I. M., Pérez Moreno, R., & Moreno Pardillo, D. M. (2018). Hipocondría en la infancia y adolescencia. Revisión bibliográfica. Revista De Psiquiatría Infanto-Juvenil, 35(1), 7-16. https://doi.org/10.31766/revpsij.v35n1a1

Resumen

El trastorno hipocondríaco se describe como la preocupación excesiva por padecer una enfermedad. Como ocurre con otros trastornos psiquiátricos, la ausencia de pruebas complementarias analíticas o de imagen para el diagnóstico complica su estudio, y el debate acerca de sus características es constante. En el caso de niños y adolescentes, los estudios son aún más escasos, dificultando la tarea de psiquiatras y pediatras cuando se encuentran ante sintomatología compatible con diagnóstico de hipocondría. Por ello, hemos querido realizar una revisión de las publicaciones más recientes en relación con este trastorno en población infantojuvenil. Tras explorar los artículos publicados en los últimos años, y a pesar de la limitación de estudios en esta población específica, es de relieve la importancia de un abordaje multidisciplinar. Una vez descartadas otras patologías, el objetivo principal es recuperar y mantener la funcionalidad propia de la edad, implicando al grupo primario de apoyo.

https://doi.org/10.31766/revpsij.v35n1a1
PDF

Referencias

Ackerknecht E, Maljuri A. Breve historia de la psiquiatría. Valencia: Seminari d’estudis sobre la ciència; 1993.

Schulte I, Petermann F. Somatoform disorders: 30 years of debate about criteria!. Journal of Psychosomatic Research. 2011;70(3):218-228.

Bailer J, Kerstner T, Witthöft M, Diener C, Mier D, Rist F. Health anxiety and hypochondriasis in the light of DSM-5. Anxiety, Stress, & Coping. 2016 Mar 3;29(2):219-39.

Dimsdale J, Sharma N, Sharpe M. What Do Physicians Think of Somatoform Disorders?. Psychosomatics. 2011;52(2):154-159.

Organización Mundial de la Salud. CIE-10. Trastornos Mentales y del Comportamiento. Décima Revisión de la Clasificación Internacional de las Enfermedades. Descripciones Clínicas y pautas para el diagnóstico. Ginebra. 1992.

Pareja MÁ. De los trastornos somatomorfos a los trastornos de síntomas somáticos y trastornos relacionados. Cuadernos de medicina psicosomática y psiquiatría de enlace. 2014(110):75-8.

Starcevic V. Should we deplore the disappearance of hypochondriasis from DSM-5?. Australian and New Zealand Journal of Psychiatry. 2013 Nov 29:0004867413515058.

Newby J, Hobbs M, Mahoney A, Wong S, Andrews G. DSM-5 illness anxiety disorder and somatic symptom disorder: Comorbidity, correlates, and overlap with DSM-IV hypochondriasis. Journal of Psychosomatic Research. 2017;101:31-37.

Starcevic V. Hypochondriasis and health anxiety: conceptual challenges. The British Journal of Psychiatry. 2013;202(1):7-8.

Sunderland M, Newby J, Andrews G. Health anxiety in Australia: prevalence, comorbidity, disability and service use. The British Journal of Psychiatry. 2012;202(1):56-61.

Gropalis M, Bleichhardt G, Witthöft M, Hiller W. Hypochondriasis, Somatoform Disorders, and Anxiety Disorders. The Journal of Nervous and Mental Disease. 2012;200(5):406-412.

Christogiorgos S, Tzikas D, Widdershoven-Zervaki MA, Dimitropoulou P, Athanassiadou E, Giannakopoulos G. Hypochondriacal anxieties in adolescence. Open Psychology Journal. 2013;6:6-9.

Sirri L, Garotti MG, Grandi S, Tossani E. Adolescents’ hypochondriacal fears and beliefs: Relationship with demographic features, psychological distress, well-being and healthrelated behaviors. Journal of psychosomatic research. 2015 Oct 31;79(4):259-64.

Mohapatra S, Deo S, Satapathy A, Rath N. Somatoform Disorders in Children and Adolescents. German J Psychiatry 2014; 17(1): 19-24.

Costello EJ, Copeland W, Angold A. Trends in psychopathology across the adolescent years: what changes when children become adolescents, and when adolescents become adults?. Journal of Child Psychology and Psychiatry. 2011 Oct 1;52(10):1015-25.

Navarro-Pardo E, Meléndez J, Sales A, Sancerni M. Desarrollo infantil y adolescente: Trastornos mentales más frecuentes en función de la edad y el género. Psicothema, 2012;24(3), 377-383.

Rask C, Elberling H, Skovgaard A, Thomsen P, Fink P. Parental-Reported Health Anxiety Symptoms in 5- to 7-Year-Old Children: The Copenhagen Child Cohort CCC 2000. Psychosomatics. 2012;53(1):58-67.

Rask C, Munkholm A, Clemmensen L, Rimvall M, Ørnbøl E, Jeppesen P et al. Health Anxiety in Preadolescence - Associated Health Problems, Healthcare Expenditure, and Continuity in Childhood. Journal of Abnormal Child Psychology. 2015;44(4):823-832.

Taylor, S, Thordarson, D S, Jang, K L, Asmundson, G J. Genetic and environmental origins of health anxiety: a twin study. World Psychiatry. 2006;5(1), 47–50.

Thorgaard M, Frostholm L, Rask C. Childhood and family factors in the development of health anxiety: A systematic review. Children’s Health Care. 2017;:1-41.

Simon AE, Borgwardt S, Lang UE, Roth B. Cenesthopathy in adolescence: An appraisal of diagnostic overlaps along the anxiety–hypochondriasis–psychosis spectrum. Comprehensive psychiatry. 2014 Jul 31;55(5):1122-9.

Diez-Quevedo C, Rangil Muñoz T, Sánchez Planell L. Situación actual de la hipocondría. Psiquiatría Biológica 2003;10(3):87-95.

Wright K, Reiser S, Delparte C. The relationship between childhood health anxiety, parent health anxiety, and associated constructs. Journal of Health Psychology. 2015;22(5):617-626.

Köteles F, Freyler A, Kökönyei G, Bárdos G. Family background of modern health worries, somatosensory amplification, and health anxiety: A questionnaire study. Journal of Health Psychology. 2014;20(12):1549-1557.

Thorgaard M, Frostholm L, Walker L, Stengaard-Pedersen K, Karlsson M, Jensen J et al. Effects of maternal health anxiety on children’s health complaints, emotional symptoms, and quality of life. European Child & Adolescent Psychiatry. 2016;26(5):591-601.

Weck F, Neng JM, Göller K, Müller-Marbach AM. Previous experiences with illness and traumatic experiences: a specific risk factor for hypochondriasis?. Psychosomatics. 2014 Aug 31;55(4):362-71.

Alberts N, Hadjistavropoulos H, Sherry S, Stewart S. Linking Illness in Parents to Health Anxiety in Offspring: Do Beliefs about Health Play a Role?. Behavioural and Cognitive Psychotherapy. 2014;44(01):18-29.

Bailer J, Witthöft M, Wagner H, Mier D, Diener C, Rist F. Childhood maltreatment is associated with depression but not with hypochondriasis in later life. Journal of psychosomatic research. 2014 Aug 31;77(2):104-8.

Cely-Serrano M. Pediatric Hypochondriasis. Developmental and Behavioral Pediatrician, Center for Child Development, Florida Hospital. http://emedicine.medscape.com/article/918506-overview

Bizzi F, Cavanna D, Castellano R, Pace C. Children’s mental representations with respect to caregivers and post-traumatic symptomatology in Somatic Symptom Disorders and Disruptive Behavior Disorders. Frontiers in Psychology. 2015;6.

Ozdemir H, Mermi O, Gurok MG, Saglam S, Yildirim H, Sec S, Atmaca SM. N-acetyl-laspartate values of hippocampus are reduced in patients with hypochondriasis. 2013.

Atmaca M, Yildirim H, Sec S, Kayali A. Pituitary volumes in hypochondriac patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010;34, 2, 344-347.

Kaplan, Benjamín J. Sadock, Virginia A. Sadock. Sinopsis de psiquiatría. Lippincott Williams and Wilkins. Wolters Kluwer, 10 Edición, 2009.

Rohlof H, Knipscheer J, Kleber R. Somatization in refugees: a review. Social Psychiatry and Psychiatric Epidemiology. 2014;49(11):1793-1804.

Khare S, Srivastava MN. Validity of Current Treatment Protocols to Overcome Hypochondriasis. Journal of clinical and diagnostic research: JCDR. 2017 Jan;11(1):VE01.

Doherty-Torstrick ER, Walton KE, Barsky AJ, Fallon BA. Avoidance in hypochondriasis. Journal of Psychosomatic Research. 2016 Oct 31;89:46-52.

Jeffers A, Benotsch E, Green B, Bannerman D, Darby M, Kelley T et al. Health anxiety and the non-medical use of prescription drugs in young adults: A cross-sectional study. Addictive Behaviors. 2015;50:74-77.

Schwind J, Neng JM, Höfling V, Weck F. Health Behavior in Hypochondriasis. The Journal of nervous and mental disease. 2015 Jul 1;203(7):493-8.

Bobevski I, Clarke D, Meadows G. Health Anxiety and Its Relationship to Disability and Service Use. Psychosomatic Medicine. 2016;78(1):13-25.

Höfling V, Weck F. Hypochondriasis Differs From Panic Disorder and Social Phobia: Specific Processes Identified Within Patient Groups. The Journal of nervous and mental disease. 2017 Mar 1;205(3):227-33.

Villadsen A, Thorgaard M, Hybel K, Jensen J, Thomsen P, Rask C. Health anxiety symptoms in children and adolescents diagnosed with OCD. European Child & Adolescent Psychiatry. 2016;26(2):241-251.

Sanatinia R, Wang D, Tyrer P, Tyrer H, Crawford M, Cooper S et al. Impact of personality status on the outcomes and cost of cognitive-behavioural therapy for health anxiety. The British Journal of Psychiatry. 2016;209(3):244-250.

Thorisdottir A, Villadsen A, LeBouthillier D, Rask C, Wright K, Walker J et al. Measurement invariance across Genders on the Childhood Illness Attitude Scales (CIAS). Journal of Psychosomatic Research. 2017;98:34-39.

Soutullo Esperón, César, and María Jesús Mardomingo Sanz. Manual de psiquiatría del niño y del adolescente. No. 616.89-053.2. Médica Panamericana, 2010.

First, Michael B. Michael B. DSM-5 Manual de diagnóstico diferencial. No. 616.89. American Psychiatric Association.

Tyrer P, Cooper S, Salkovskis P, Tyrer H, Crawford M, Byford S et al. Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial. The Lancet. 2014;383(9913):219-225.

Greeven A, van Balkom AJ, Visser S, Merkelbach JW, van Rood YR, van Dyck R, Van der Does AW, Zitman FG, Spinhoven P. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. American Journal of Psychiatry. 2007 Jan;164(1):91-9.

Fallon B, Ahern D, Pavlicova M, Slavov I, Skritskya N, Barsky A. A Randomized Controlled Trial of Medication and Cognitive-Behavioral Therapy for Hypochondriasis. American Journal of Psychiatry. 2017;174(8):756-764. 49. Thomson A, Page L. Psychotherapies for hypochondriasis. The Cochrane Library. 2007 Jan 1.

Sørensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. A randomized clinical trial of cognitive behavioural therapy versus shortterm psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychological medicine. 2011 Feb 1;41(02):431-41.

Weck F. Treatment of mental hypochondriasis: a case report. Psychiatric Quarterly. 2014 Mar 1;85(1):57-64.

Schweitzer PJ, Zafar U, Pavlicova M, Fallon BA. Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. Journal of clinical psychopharmacology. 2011 Jun 1;31(3):365-8.

Descargas

Los datos de descarga todavía no están disponibles.